|Approvals/Requirements Satisfied by eRADIMAGING Courses|
|~ ASRT approval for ARRT® Category A credit||~ MDCB approval by the Medical Dosimetrist Certification (Selected Courses)|
|~ ARMRIT accepted (All MRI Courses)||~ CAMRT and Sonography Canada recognize the ASRT approval (All Courses)|
|~ ARDMS accepted (All Courses)||~ Florida approval for all courses 1 credit or more|
|~ NMTCB accepted (All Courses)||~ California CE requirements met for all radiography courses|
|~ All Courses eligible of international radiographers' CPD requirements||~ All Courses available for RRAs|
|~ ASRT and MDCB are approved continuing education providers of ARRT® and all courses are accepted by ARRT®|
Examining the Role of High-Resolution Breast PET in the Screening, Diagnosis, and Management of Breast Cancer
Linda Giering, PhD*
*Medical Writer, Matawan, New Jersey
Address correspondence to: Linda Giering, PhD. Email: email@example.com.
Disclosure statement: The author reports having no significant financial or advisory relationships with corporate organizations related to this activity.
Mammography is the standard breast cancer screening procedure, although it is constrained by low specificity in the detection of malignancy and low sensitivity in women with dense breast tissue, implants, and other conditions. Magnetic resonance imaging (MRI), is used to replace or complement mammography in some patients, because the early detection of breast cancer is critical for prompt treatment and long-term survival of patients. However, some patients are unable to undergo MRI imaging. Nuclear imaging with positron emission tomography (PET) plays a role in breast cancer. PET measures metabolism and identifies changes at the cellular level. PET/computed tomography (PET/CT) imaging allows for a more accurate assessment by merging the anatomic localization to the functional image. PET is not a diagnostic tool in early breast cancer detection, primarily because of low sensitivity, especially for sub-centimeter and low-grade tumors. Positron emission mammography (PEM), now referred to as high-resolution breast PET imaging, provides increased spatial resolution to overcome some of the limitations of conventional PET/CT. These systems have demonstrated higher detectability than conventional PET/CT and comparable or better sensitivity than MRI. The ability to target the lesions visible on breast PET imaging with PET-guided breast biopsy systems adds to its utility in the early diagnosis of breast cancer. This review explores the role of breast PET imaging compared with other imaging modalities in breast cancer and discusses how these techniques are being used in clinical practice.
Full Course Content available to active members of eRADIMAGING.com
* This sample course is for reference purposes only. It is not currently available for earning CE credits. To earn ARRT CE credits please subscribe to eRADIMAGING where you will see a complete listing of all active and eligible CE courses.